Overview

Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy

Status:
Not yet recruiting
Trial end date:
2027-02-01
Target enrollment:
Participant gender:
Summary
This is a pilot phase, randomized, double-blinded feasibility pilot study of AHCC in participants with ovarian cancer.
Phase:
Phase 2
Details
Lead Sponsor:
University of California, Davis
Collaborators:
Amino Up Chemicals Co., Ltd.
National Cancer Institute (NCI)